Contact PR

To use this feature, join Babbler easily !

arrow_back

Babbler allows PR people and reporters to collaborate a better way.

By joining Babbler you will be able to access hundreds of newsrooms and PR contacts from your industrie(s) and also share with them your upcoming needs.

Their newsrooms are already on Babbler

You're 1 click away from signing up

Previous

Nice to see you again !

Press release

Molecular Diagnostics Market Forecast: Technological Growth Map with an Impact-Analysis
timer minutes reading time minute reading time

Copy link
The molecular diagnostics market is projected to grow from US$ 16,258.97 million in 2021 to US$ 36,176.65 million by 2028; it is expected to grow at a CAGR of 12.1% during 2021-2028.

According to the latest study on "Molecular Diagnostics Market Forecast to 2028 – COVID-19 Impact and Global Analysis - by Disease Area, Technology, Product and Services, and End User,” the market is projected to grow from US$ 16,258.97 million in 2021 to US$ 36,176.65 million by 2028; it is expected to grow at a CAGR of 12.1% during 2021–2028. The report highlights the trends prevailing in the global molecular diagnostics market and drivers and deterrents pertaining to the market growth.

Based on technology, the molecular diagnostics market is segmented into polymerase chain reaction, isothermal nucleic acid amplification technology, DNA sequencing and next-generation sequencing, in situ hybridization, DNA microarray, and others. The polymerase chain reaction segment would account for the largest share of the market in 2021.

An increase in demand for point-of-care devices, developments by market players, and a rise in the prevalence of associated diseases are driving the molecular diagnostics market. However, the increasing prevalence of associated diseases are expected to limit market growth.

Abbott; Agilent Technologies, Inc.; Thermo Fisher Scientific Inc.; F. Hoffmann-La Roche Ltd.; TBG Diagnostics Limited; QIAGEN; bioMérieux SA; Siemens Healthineers AG; Illumina, Inc.; Danaher; and Novartis AG are among the prominent players operating in the molecular diagnostics market. These companies are focusing on partnerships, product launches, collaborations, and other business strategies to sustain their position in the market. For instance, in October 2021, Siemens Healthineers launched the CLINITEST Rapid COVID-19 Antigen Test Rapid Antigen Test for the Detection of SARS-CoV-2. The CLINITEST Rapid COVID-19 Antigen Test produces results in 15 minutes.

Get Sample PDF:  https://www.theinsightpartners.com/sample/TIPRE00003124/   

The report segments the molecular diagnostics market as follows:

The molecular diagnostics market is segmented based on disease area, technology, product and services, and end user. Based on disease area, the market is segmented into oncology, infectious disease, genetic testing, cardiac diseases, immune system disorders, and others. In terms of technology, the molecular diagnostics market is further segmented into polymerase chain reaction, isothermal nucleic acid amplification technology, DNA sequencing and next-generation sequencing, in situ hybridization, DNA microarray, and others. Based on product and services, the market is segmented into assays and kits, instruments, services and software. In terms of end user, the molecular diagnostics market is segmented into hospitals and clinics, diagnostic laboratories, research and academic institutes, and others. Based on geography, the molecular diagnostics market is segmented into North America (the US, Canada, and Mexico), Europe (France, Germany, Italy, the UK, Spain, and the Rest of Europe), Asia Pacific (India, Singapore, Malaysia, Philippines, Thailand, Indonesia, Vietnam, China, Japan, Australia, South Korea, and the Rest of Asia Pacific), the Middle East & Africa (Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa), and South and Central America (Brazil, Argentina, and the Rest of South and Central America).

Buy Now: https://www.theinsightpartners.com/buy/TIPRE00003124/    

Molecular Diagnostics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Disease Area (Oncology, Infectious diseases, Genetic testing, Cardiac diseases, Immune system disorders, and Others); Technology (Polymerase Chain Reaction (PCR), Isothermal Nucleic Acid Amplification Technology (INAAT), DNA Sequencing and Next-Generation Sequencing (NGS), In Situ Hybridization, DNA Microarray, and Others); Product and Services (Assays and Kits, Instruments, Services and Software); End User (Hospitals and Clinics, Diagnostic Laboratories, Research and Academic Institutes, and Others) and Geography

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us:

If you have any queries about this report or if you would like further information, please contact us:

Contact Person: Sameer Joshi

E-mail: sales@theinsightpartners.com

Phone: +1-646-491-9876

inscrit avec succès

Congratulations, you're registered on Babbler!

Discover now all the news waiting for you on Babbler: visit your newsfeed.!

Your topics have been selected, you can change it by clicking here